Aspen Neuroscience

Description

Aspen Neuroscience develops autologous iPSC-derived cell therapies using a patient’s own cells, initially targeting Parkinson’s disease by replacing lost dopamine-producing cells in affected brain regions.

Aspen Neuroscience is located in the San Diego ecosystem.

Related

• Kyverna Therapeutics (San Diego)Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing…
• Artiva Biotherapeutics ($ARTV)Develops off-the-shelf, non-genetically modified natural killer cell therapies for deep B-cell depletion, aiming to help patients with…
• Poseida Therapeutics (Roche)Develops cell therapy candidates and related platform technologies, with legacy programs in a biotechnology pipeline for medicines…
• Boundless Bio ($BOLD)Develops ecDNA-directed cancer therapies that target vulnerabilities in cancer cells for patients with intractable oncogene-amplified…
• bluebird bioDevelops one-time gene addition treatments for rare hematologic diseases, using patients' own cells and patient support services to help…
• Allen Institute for Brain ScienceBuilds brain cell atlases, connectome maps, and analysis platforms to help researchers study mammalian brain organization across…
• Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
• Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
• Connect FoundationPremier San Diego innovation network. Runs Springboard accelerator and Innovation Connect programs for tech and life-science startups…
• Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…